Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × empagliflozin × Clear all

Phase

Status

Sponsor Class

OTHER 6 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 857 Carboplatin 805 Paclitaxel 788 Gemcitabine 663 Cisplatin 637 Docetaxel 594 Bevacizumab 517 Pemetrexed 414 Nivolumab 404 Cyclophosphamide 404 Capecitabine 390 Fluorouracil 336 Dexamethasone 333 Rituximab 320 Oxaliplatin 287 Injections 284 atezolizumab 254 Trastuzumab 248 Cetuximab 234 Leucovorin 233 Irinotecan 218 130-nm albumin-bound paclitaxel 218 Prednisone 215 Doxorubicin 212 Ipilimumab 188 Lenalidomide 187 Fulvestrant 182 fludarabine 180 durvalumab 173 venetoclax 165

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03424005 2026-03-16

Morpheus-panBC

Hoffmann-La Roche

Phase 1/2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡